Amifostine (WR2721) Confers DNA Protection to Cisplatin-Treated Murine Peripheral Blood Leukocytes
Amifostine [S-2-3-aminopropil amino ethyl phosphorotioic acid], a modulator agent for antineoplastic drugs involved in free radicals generation has given controversial results in cisplatin treated leukocytes in vitro . We have evaluated the amifostine protection over leukocytes in vivo , using comet...
Main Authors: | E. A. Prieto González, A. G. Fuchs, González S. Sánchez |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-07-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.2203/dose-response.08-026.Prieto |
Similar Items
-
Effect of Amifostine (WR-2721) on Bacterıal Translocation After Burn Injury: An Experımental Study
by: Emre Karakaya, et al.
Published: (2021-10-01) -
Antiretroviral activity of aminothiols, WR2721 and WR1065
by: Walker Dale M, et al.
Published: (2006-12-01) -
Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits
by: Karanikolas Menelaos, et al.
Published: (2009-09-01) -
Radioprotective Effects of Amifostine (WR-2721) or Cystamine on Radiation Damage and Its Repair in Rats Whole Body Exposed to Fission Neutrons
by: Pavel Kuna, et al.
Published: (2004-01-01) -
Amifostine (WR-2721) Mitigates Cognitive Injury Induced by Heavy Ion Radiation in Male Mice and Alters Behavior and Brain Connectivity
by: Sydney Weber Boutros, et al.
Published: (2021-11-01)